Pathology of VEGF signaling in cancers is characterized by hyperproduction of VEGF ligand family (VEGF-A, VEGF-B, VEGF-C, VEGF-D) by tumor and tumor-infiltrating cells. This evidence concerns the gene VEGFD and neoplasm.